MEIRAGTX HOLDINGS PLC

MGTX NASDAQ
22.08
+0.17
+0.75%
Opening 09:48 08/22 EDT
Open
21.91
Prev Close
21.91
High
22.10
Low
21.80
Volume
23.71K
Avg Vol (3M)
178.90K
52 Week High
30.23
52 Week Low
8.53
% Turnover
0.09%
Market Cap
600.09M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers MEIRAGTX HOLDINGS PLC MGTX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

MeiraGTx Holdings plc is a clinical-stage therapy company. The Company develops gene therapy treatments for a range of inherited and acquired disorders. It is focused on developing therapies for ocular diseases, including rare inherited blindness, as well as Xerostomia, radiation treatment for head and neck cancers and neurodegenerative diseases, such as amyothrophic lateral sclerosis (ALS). It is also developing transformative technology to enable the use of small molecules to turn gene therapy product candidates on and off. It is focused on three areas of unmet medical needs, including inherited retinal diseases, severe forms of xerostomia and neurodegenerative diseases. Its product candidates include AAV-CNGB3, AAV-CNGA3, AAV-RPGR, AAV-RPE65, A006, AAV-AQP1 and AAV-UPF1.
MORE >

Recently

Name
Price
%Change